Mitochondrial protein plays key role in glioblastoma and therapeutic resistance.

Out of 577 samples, they found that the CHCHD2 genes had higher expression in tumor cells, compared to non-tumor tissue, and was higher in advanced cases of glioblastoma. Keywords: Animal Science; Bioengineering; Biomolecular Engineering; Bionanotechnology; Biotechnology; Cancer; Carl R. Woese Institute for Genomic Biology University of Illinois at Urbana-Champaign; Drugs and Therapies; Emerging Technologies; Engineering; Genetics; Glioblastomas; Health and Medicine; Mitochondrial Proteins; Nanobiotechnology; Nanotechnology; Oncology; Therapeutics; Therapy EN Animal Science Bioengineering Biomolecular Engineering Bionanotechnology Biotechnology Cancer Carl R. Woese Institute for Genomic Biology University of Illinois at Urbana-Champaign Drugs and Therapies Emerging Technologies Engineering Genetics Glioblastomas Health and Medicine Mitochondrial Proteins Nanobiotechnology Nanotechnology Oncology Therapeutics Therapy 607 607 1 10/30/23 20231030 NES 231030 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Veterinary Week -- Glioblastoma is the most common type of brain tumor that affects adults and, unfortunately, still remains incurable. [Extracted from the article]